Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

VICTRELIS

BOCEPREVIR

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview VICTRELIS is listed in Drugs@FDA under application 202258 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BOCEPREVIR Form and strength CAPSULE;ORAL - 200MG Sponsor MERCK SHARP DOHME Submission history Latest submission status date: 2017-01-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview VICTRELIS is listed in Drugs@FDA under application 202258 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BOCEPREVIR Form and strength CAPSULE;ORAL - 200MG Sponsor MERCK SHARP DOHME Submission history Latest submission status date: 2017-01-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.